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Book Reviews
An Introduction to Flow Cytometry
J.V. Watson, Cambridge: CUP, 1991, 443 pp. £50.00.
This is a very handsome volume consisting of 443 pages and
numerous diagrams. The book is divided into 15 chapters
with, in addition, a brief epilogue. The list of chapter head-
ings is as follows:
Chapter 1 - Introduction; 2 - Fluid flow dynamics; 3 -
Light and Optics; 4 - Electronics; 5 - Computing; 6 - Cell
sorting; 7 - Preparation and staining; 8 - Miscellaneous
techniques (e.g. slit-scanning and rare-event analysis);
9 - Instrument performance; 10 - Light scatter applications;
11 - Nucleic acid analysis; 12 - Nucleic acids and protein;
13 - Chromosomes; 14 - Dynamic cellular events; 15 -
Applications in Oncology.
This book is certainly more than can be described by a
simple list of chapter headings. Dr Watson describes his
book as an 'Introduction', by which he seems to mean that it
does not attempt to be comprehensive. However, topics
which are covered in the book tend to be dealt with in some
detail, whilst others are excluded completely. As is inevitable,
the topics included are related strongly to the authors own
interests and techniques described are heavily influenced by
procedures in his own laboratory. Thus, Dr Watson's enthu-
siasm for the technology of flow cytometry is mirrored by the
fact that ten of the fifteen chapters are instrument related.
Clearly, and with justification, the author feels that an under-
standing of how flow cytometers work is a necessary prere-
quisite to obtaining meaningful results with such instruments.
This addresses a real danger, attached particularly to modern
analytical flow cytometers, that it is all too easy to stick a
tube on one end of the machine and produce a vast amount
of 'data' at the other end without understanding anything
that goes on it between. Sadly, this can lead to the produc-
tion of mountains of useless numbers.
Topics which are well covered in this book, in addition to
instrument-related subjects, are various aspects of nucleic
acid analysis including cell kinetics, the inclusion of time as a
parameter in flow cytometric studies and staining of nuclear
antigens. An example of something excluded (which is point-
ed out by the author himself) is Immunology - a vast field of
flow cytometric applications.
Although this is not an all-encompassing encyclopaedia of
flow cytometry, it most certainly is a book that I would want
on my bookshelf. Dr Watson has managed to convey his
enthusiasm for the subject and at the same time, produce an
extremely readable book. He has very successfully included
analogies and asides concerning everything from the principle
on which aviation is based, to comments on the vortex
produced during emptying of the bath. The anecdotes and
analogies, of which there are many, are always relevant and
they lighten the text of what is a very technical book.
Another great virtue of this book, is the readiness of the
author to give important information or advice, even when it
might seem 'obvious'. A good example of this is on p. 136,
where the need to filter large lumps of debris from cell (or
nuclear) suspensions, if blocking of the machine is to be
avoided, is emphasised. When I first started doing flow cyto-
metry, I was amazed how many people repeatedly blocked
their machines for lack of this precaution.
I have few points of disagreement with the book but where
I do they are minor and are generally matters of opinion -
not fact. For example, Dr Watson suggests on p. 384 that the
BrdU technique for assessing the rate of cell proliferation,
might be useful for developing 'fractionated' chemotherapy
schedules for the treatment of cancer. Given my own
research experience, I would be less sanguine about.the value
of cell kinetic measurements in the application of cancer
chemotherapy.
What I can do with certainty, is recommend this book to
anyone with an interest in flow cytometry, particularly those
who have a desire to understand how their instrument works.
I feel this book should be on the shelf (and taken off it
regularly) in all flow cytometry laboratories.
R.S. Camplejohn
Guide to Flow Cytometry Methods
W. McLean Groghan & J.M. Collins, New York: Marcel
Dekker Inc., 1990, 240 pp. $99.75 (USA & Canada), $199.50
(Others).
This is a compact book consisting of 15 chapters in 228
pages. The authors have run a flow cytometry laboratory
equipped with Coulter Flow Cytometers since 1976. They
state, in the preface, that the book began as a library of
protocols, notes and reprints. A short introductory chapter is
followed by chapters on the preparation of cell suspensions
and DNA analysis. Chapter 4 is a brief description of the
assessment of cellular viability and this is followed by a long
chapter on light scatter and then by a brief discussion of
immunofluorescence. Cell sorting is also dealt with fairly
succinctly in Chapter 7 and this is followed by a series of
brief chapters on mitochondrial stains, intracellular pH,
intracellular calcium, glutathione, fluorescence anisotropy
and membrane fluidity, cell surface receptors, cellular mem-
brane potential and a final chapter on miscellaneous applica-
tions. The choice of subject material for any book is clearly
influenced by personal interest and experience. However, I
would have liked certain topics, such as chromosomal karyo-
typing and the combination of DNA with surface and inter-
nal cellular markers, to be covered. In contrast, I felt the
chapter on light scatter was excessively long in the context of
this book.
I was also unimpressed with the introductory chapter
which seemed to try to cover too much ground without
adequately dealing with the basic principles of flow cyto-
metry. My main two criticisms of the book relate firstly,
however, to its organisation and the second to its perceived
goal. Looking first at the stated aims of the book; from its
title and the authors views set out in the preface, this book
was to be a practical guide, i.e. a 'methods' book. As such,
each chapter includes protocols for the various techniques
described. However, in each chapter the authors attempt a
mini-review of the literature, which to my mind, is often too
superficial to be useful but, nevertheless, takes up consid-
erable space throughout the book. As the book is short, this
leads to many practical applications being also dealt with too
superficially. If we take Chapter 3 on DNA analysis as an
example, pages 47 to 57 are spent reviewing the vast litera-
ture on clinical DNA flow cytometry studies. This means that
kidney tumours, on which there is a considerable literature,
get five lines, ovarian tumours four lines, and so on.
This brings me to my second major criticism of the book,
namely the organisation within chapters and the order in
which topics are covered. Again, we can take Chapter 3 as an
example. Computer analysis of DNA data is mentioned on
page 34. This is followed by a brief review of the literature
and other sundry items. Then on page 58, another aspect of
data analysis, namely the use of DNA standards to define
ploidy levels, is referred to. The effect is to yield a disjointed
chapter with no coherent section on the important topic of
data analysis. I would have preferred this chapter to have
run along the lines of principles of DNA flow cytometry,
preparation and staining ofcell suspension, collection of data
and finally, data analysis.BOOK REVIEWS 415
A minor criticism of the book, is that few of the practical
protocols quoted seem to have been improved by application
in the authors' own laboratory. If one uses a technique
regularly, it is usual to come up with little ways ofimproving
the method. In this book, most of the protocols seem to be
copied unchanged from the original source. For example, in
protocol 3.11 on performing DNA measurements from para-
ffin-embedded material, the authors suggest the use of 30 ym
sections, whilst it has been recognised for some time, that
this is not the optimum and that 50 m sections often give
significantly better results. Further, many laboratories have
automated this technique, to make it quicker and more con-
venient to perform.
Although I have used Chapter 3 as an example, my im-
pression is that these criticisms apply throughout the book.
Undoubtedly, this book contains useful information but the
market for flow cytometry books is becoming more com-
petitive. From the middle of 1990 to mid-1992, at least eight
flow cytometry books have, or are scheduled to, appear on
the market. Thus, any new book needs to have a clear
objective and to be well written and organised. In my view,
this book tends to fall between stools in its aims, and could
have benefited from a better level of organisation. Given the
availability of alternative books, I would find it hard to
recommend this book to new colleagues or students.
R.S. Camplejohn
Hematopoietic Growth Factors in Clinical Applications
Edited by R. Mertelsmann and R. Herrmann, New York:
Marcel Dekker Inc., 1990, 240 pp. $99.75 (USA and
Canada), $199.50 (Others).
Since the first haemopoietic growth factors became available
for clinical testing over 5 years ago, there has been a rapid
expansion in the literature. The two editors Roland Mertels-
mann and Friedhelm Herrmann of this multi-author text,
have made major contributions to this field. They have invit-
ed contributors to initially address the biology and basic
concepts of haemopoietic growth factors before embarking
on clincial applications.
As might be expected with over 75 authors, there is some
repetition and the standard of contribution varies. The pre-
clinical chapters give a good review of the cytokines available
for testing, their production, mechanism ofaction, and recep-
tor expression. The book then naturally progresses to the
studies in sub-human primates before coming through to
man. The clinical data are predominantly from Phase I and
II trials of Granulocyte and Granulocyte-Macrophage Col-
ony Stimulating Factors, although data are presented on
Erythropoietin and Interleukin-3. This section deals mainly
with reduction in the period of neutropenia after chemo-
therapy or bone marrow transplantation, but there are also
chapters on myelodysplasia and aplastic anaemia. There is an
interesting section on the effect of colony stimulating factors
on malignant cells. This concentrates predominantly on the
potentially advantageous use of these agents to recruit mye-
loid leukaemic cells into cycle prior to chemotherapy. The
book concludes with pre-clinical data on Interleukin 4 and 6
which have just entered clinical trials.
It may be slightly too early to give firm recommendation
for the clinical indication for the use of haemopoietic growth
factors, but I felt that an attempt should have been made to
have a chapter in which the clinical data presented were
critically evaluated. Now that these agents are being market-
ed, I suspect that clinicians having read the title of this book
would have expected more guidance and help on the best
way to utilise these powerful agents in the most cost bene-
ficial manner for their patients. With the plethora of talent
and experience available from the authors contributing to
this book, it should have been possible to entice one of them
to have written this finale.
A review at this time can only be a 'snapshot' of this
rapidly progressing field. Readers will, however, find that this
review will give them an excellent basis of knowledge critic-
ally to evaluate publications as they appear. It will appeal
predominantly to clinicians wishing to rapidly assimilate the
basic science as well as the clinical results.
J.H. Scarffe
Cancer Screening
edited by A.B. Miller, J. Chamberlain, N.E. Day, M.
Hakama and P.C. Prorok, Cambridge: Cambridge University
Press, 1991, 438 pp. £45.00, $85.00.
This book is the report of a workshop 'to uptake conclusions
on screening for cancer of sites previously considered, and to
evaluate some new sites' held in April 1990 and is the fifth
monograph arising from the UICC Project on Evaluation of
Screening for Cancer. In one volume the 'State of the Art' on
screening for cancers of the breast, colorectum, cervix, ovary,
prostate, stomach, nasopharynx, and for malignant mela-
noma and neuroblastoma is brought together. Each cancer is
reported in a separate section comprising a number of
chapters (44 in all) written by 88 experts.
Each section begins with a brief summary of the state of
the art on screening for that particular cancer including a list
of recommendations for research. This is followed by a
number of chapters from different authors' presentations at
the workshop and finally an edited summary of the discus-
sion. The book is clearly laid out for reference purposes and
presents the concepts of screening straightforwardly. The
Editors state, in their Preface, that the book is targeted at
those 'interested in screening for cancer including govern-
ment and non-government organisations concerned with
cancer control' and cancer researchers. Experts in cancer-
screening may find the book rather too simple but it is
pitched at the right level for the non-expert. Those hoping
that the book will summarise the results of all the various
studies to date will be disappointed; in Chapter 1 on the UK
Trial, for example, the discussion is mainly concerned with
sensitivity, specificity and biopsy rates.
The first section on breast cancer contains five chapters
each on one of the well-known trials of screening - the UK
trial, the trials from Finland, the Swedish 2-County trial, the
Malmo trial and that from Canada. Different aspects of these
studies are described and some of the puzzling differences in
results discussed. A sixth chapter on breast self-examination
(BSE) as a strategy for downstaging in developing countries
and the importance, and feasibility, of giving adequate treat-
ment without major technological investment is unfortunately
too early to give any results of the USSR/Germany/WHO
trial. A clearly presented account ofthe principles involved in
different types of cost-effectiveness analysis completes this
section.
The section on cervical screening includes chapters on
natural history, a description of the screening programmes in
the Nordic countries indicating the stark contrast between
the success of the best-organised programmes there to the
relative lack of success of the programmes in Canada, and
indeed in the UK. The importance of 'political will' in ensur-
ing the success of national programmes and the difficulties of
reducing the overscreening of low-risk groups are rightly
emphasised. Chapter 18 contains an excellent discussion of
the evidence for the effect oftiming ofreferral for colposcopy
in terms of degree of dysplasia. While the first four chapters
in the section consider cervical screening in developing coun-
tries where as few as 5% of women may have been screened
within the previous 5 years. The enormous problems of
setting up and evaluating even the simplest of organised
programmes (which have in the past at least, defeated even-
some developed countries) are discussed. This surely must be
a major challenge for preventative medicine in the next
decade.
Sections 1 and 3 thus discuss two cancer sites where there
is sufficient evidence of the potential or actual advantages of